Some health experts argue we should scrap daylight saving time in favor of permanent standard time. Yet just this week, the ...

The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic ...

Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug Wegovy ​for the ...

A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging ...

Novo Nordisk's Wegovy receives CDSCO approval as India's first GLP-1 treatment for fatty liver disease, addressing rising ...

Researchers develop a new way of assessing a person’s risk of heart failure or death, by using AI during chest scans to measure the size of the pectoral muscle ...

Doctors are warning that popular GLP-1 medications used for diabetes and weight loss, including drugs such as Ozempic and ...

For an ALS patient, losing weight can cause the condition to progress faster.

Novo Nordisk said about two in three people in India have fatty liver disease, which offers immense potential for the ...

Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic ...

New research published in The American Journal of Preventive Medicine and presented at this year's International Congress on ...

Researchers have developed a targeted fibrosis screening strategy that reduces the number of adults flagged for testing, ...